Skip to main content

Artivion, Inc.

AORT
Exchange
NYSE
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0000784199

In the last 90 days, Artivion, Inc. insiders filed 0 open-market purchases and 6 sales; 206 institutions reported holding it in 13F filings for Q2 2026, worth $1.03B in total; no superinvestor holds it.

Q4 2023 vs. Q3 2023

How the institutions holding Artivion, Inc. changed between Q3 2023 and Q4 2023.

All holders in Q4 2023All holders in Q3 2023

13F holders of AORT: Q3 2023 compared with Q4 2023
MeasureQ3 2023Q4 2023Change
Holders1421420
Shares34.0M34.1M+102.1K (+0.3%)
Value$515.8M$610.4M+$94.6M (+18.3%)

New holders (15)

Institutions that held Artivion, Inc. at the end of Q4 2023 but not at the end of Q3 2023.

Institutions new to AORT in Q4 2023
InstitutionSharesValue% of portfolio
Balyasny Asset Management LLC64,932$1.16M0.00%
Exchange Traded Concepts, LLC51,223$915.9K0.02%
AQR Capital Management LLC23,212$415.0K0.00%
Cresset Asset Management, LLC18,011$322.0K0.00%
Twinbeech Capital LP14,209$254.1K0.00%
Occudo Quantitative Strategies LP14,117$252.4K0.03%
Nebula Research & Development LLC13,751$245.9K0.07%
nVerses Capital, LLC–$209.2K0.58%
Simplex Trading, LLC3,182$56.0K0.00%
GAMMA Investing LLC1,309$21.9K0.01%
Colonial Trust Advisors925$16.5K0.00%
Lindbrook Capital, LLC156$2.79K0.00%
Advisory Services Network, LLC105$1.88K0.00%
Valley National Advisers Inc80$1.00K0.00%
JFS Wealth Advisors, LLC27$4830.00%

Sold out (15)

Institutions that held Artivion, Inc. at the end of Q3 2023 and filed for Q4 2023 without it.